title: Squamous cell carcinoma in a chronic myelogenous leukemia patient treated with imatinib mesylate.
authors.affiliation: Department of Dermatology, Kitami Red Cross Hospital, Kitami, Japan; Department of Dermatology, Asahikawa Medical University, Asahikawa, Japan.
authors.forename: Mizue
authors.initials: M
authors.lastname: Fujii
authors.forename: Takeshi
authors.initials: T
authors.lastname: Iwasaki
authors.forename: Ichiro
authors.initials: I
authors.lastname: Takahashi
authors.forename: Kazunori
authors.initials: K
authors.lastname: Kishiyama
authors.forename: Masaru
authors.initials: M
authors.lastname: Honma
authors.forename: Hidetoshi
authors.initials: H
authors.lastname: Takahashi
authors.forename: Akemi
authors.initials: A
authors.lastname: Ishida-Yamamoto
authors.forename: Hajime
authors.initials: H
authors.lastname: Iizuka
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002294:Carcinoma, Squamous Cell / Q000139:chemically induced* / Q000473:pathology; D006801:Humans; D000068877:Imatinib Mesylate / Q000009:adverse effects*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications / Q000188:drug therapy*; D008297:Male; D016609:Neoplasms, Second Primary / Q000139:chemically induced* / Q000473:pathology; D012878:Skin Neoplasms / Q000139:chemically induced* / Q000473:pathology
chemical_list: D000970:Antineoplastic Agents; D000068877:Imatinib Mesylate